| Striatal interneurones: chemical, physiological and morphological characterization Y Kawaguchi, CJ Wilson, SJ Augood, PC Emson Trends in neurosciences 18 (12), 527-535, 1995 | 1463 | 1995 |
| Regional and cellular gene expression changes in human Huntington's disease brain A Hodges, AD Strand, AK Aragaki, A Kuhn, T Sengstag, G Hughes, ... Human molecular genetics 15 (6), 965-977, 2006 | 891 | 2006 |
| Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin … A Kuhn, DR Goldstein, A Hodges, AD Strand, T Sengstag, C Kooperberg, ... Human molecular genetics 16 (15), 1845-1861, 2007 | 379 | 2007 |
| Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease P Guidetti, RE Luthi-Carter, SJ Augood, R Schwarcz Neurobiology of disease 17 (3), 455-461, 2004 | 297 | 2004 |
| Expression of α‐synuclein, parkin, and ubiquitin carboxy‐terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease SM Solano, DW Miller, SJ Augood, AB Young, JB Penney Jr Annals of Neurology: Official Journal of the American Neurological …, 2000 | 260 | 2000 |
| Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with … T Ohnuma, SJ Augood, H Arai, PJ McKenna, PC Emson Molecular brain research 56 (1-2), 207-217, 1998 | 256 | 1998 |
| Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain PF Shelbourne, C Keller-McGandy, WL Bi, SR Yoon, L Dubeau, NJ Veitch, ... Human molecular genetics 16 (10), 1133-1142, 2007 | 228 | 2007 |
| Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease SJ Augood, RLM Faull, PC Emson Annals of Neurology: Official Journal of the American Neurological …, 1997 | 218 | 1997 |
| Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellularin situ hybridization study SJ Augood, RLM Faull, DR Love, PC Emson Neuroscience 72 (4), 1023-1036, 1996 | 200 | 1996 |
| Gene expression profiling in the post-mortem human brain—no cause for dismay S Bahn, SJ Augood, M Ryan, DG Standaert, M Starkey, PC Emson Journal of chemical neuroanatomy 22 (1-2), 79-94, 2001 | 183 | 2001 |
| TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion K Rostasy, SJ Augood, JW Hewett, JC Leung, H Sasaki, LJ Ozelius, ... Neurobiology of disease 12 (1), 11-24, 2003 | 180 | 2003 |
| Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain SJ Augood, DM Martin, LJ Ozelius, XO Breakefield, JB Penney Jr, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 165 | 1999 |
| Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum MT Herrero, SJ Augood, EC Hirsch, F Javoy-Agid, MR Luquin, Y Agid, ... Neuroscience 68 (4), 1189-1198, 1995 | 163 | 1995 |
| Expression of the early‐onset torsion dystonia gene (DYT1) in human brain SJ Augood, JB Penney Jr, IK Friberg, XO Breakefield, AB Young, ... Annals of Neurology: Official Journal of the American Neurological …, 1998 | 161 | 1998 |
| Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABAA receptor α-1 subunit messenger RNA and human GABA transporter-1 … T Ohnuma, SJ Augood, H Arai, PJ McKenna, PC Emson Neuroscience 93 (2), 441-448, 1999 | 154 | 1999 |
| Dopamine transmission in DYT1 dystonia: A biochemical and autoradiographical study SJ Augood, Z Hollingsworth, DS Albers, L Yang, JC Leung, B Muller, ... Neurology 59 (3), 445-448, 2002 | 146 | 2002 |
| Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease KA Harrington, SJ Augood, AE Kingsbury, OJF Foster, PC Emson Molecular brain research 36 (1), 157-162, 1996 | 135 | 1996 |
| Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment DS Albers, SJ Augood, LCH Park, SE Browne, DM Martin, J Adamson, ... Journal of neurochemistry 74 (2), 878-881, 2000 | 120 | 2000 |
| Transcriptional dysregulation in striatal projection-and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1 B Zucker, R Luthi-Carter, JA Kama, AW Dunah, EA Stern, JH Fox, ... Human molecular genetics 14 (2), 179-189, 2005 | 117 | 2005 |
| Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a co-expression study SJ Augood, PC Emson Molecular brain research 22 (1-4), 204-210, 1994 | 112 | 1994 |
